Furthermore, HGF-treated A549 and 95D cells have undergone EMT and exhibited enhanced invasiveness and motility, and c-Met inhibitors, SU11274 can suppress the effects of HGF, suggesting HGF/c-Met signaling pathway could be a therapeutic target of lung cancers. Here, HGF is linked to lung carcinoma.